The Probiotics in Pediatric Asthma Management (PROPAM) Study in the Primary Care Setting: A Randomized, Controlled, Double-Blind Trial with Ligilactobacillus salivarius LS01 (DSM 22775) and Bifidobacterium breve B632 (DSM 24706)

Table 1

Baseline characteristics.

	Total	Placebo	Active treatment
Age
Sex
Female	182 (43.1%)	91 (43.3%)	91 (42.9%)
Male	240 (56.9%)	119 (56.7%)	121 (57.1%)
Living
City	291 (69.0%)	143 (68.1%)	148 (69.8%)
Rural	131 (31%)	67 (31.9%)	64 (30.2%)
Passive smoking at home
No	246 (58.3%)	125 (59.5%)	121 (57.1%)
Father	76 (18.0%)	39 (18.6%)	37 (17.5%)
Mother	32 (7.6%)	15 (7.1%)	17 (8.0%)
Both	57 (13.5%)	26 (12.4%)	31 (14.6%)
Other	11 (2.6%)	5 (2.4%)	6 (2.8%)
School attendance
No	50 (11.8%)	24 (11.4%)	26 (12.3%)
Yes	372 (88.2%)	186 (88.6%)	186 (87.7%)
Family atopy
Yes	320 (75.8%)	168 (80.0%)	152 (71.7%)
No	75 (17.8%)	30 (14.3%)	45 (21.2%)
Sensitized children
Yes	210 (49.8%)	104 (49.5%)	106 (50%)
No	212 (50.2%)	106 (50.5%)	106 (50%)